Low level sequence variant analysis of recombinant proteins: an optimized approach.

Sequence variants in recombinant biopharmaceuticals may have a relevant and unpredictable impact on clinical safety and efficacy. Hence, their sensitive analysis is important throughout bioprocess development. The two stage analytical approach presented here provides a quick multi clone comparison o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anne Zeck, Jörg Thomas Regula, Vincent Larraillet, Björn Mautz, Oliver Popp, Ulrich Göpfert, Frank Wiegeshoff, Ulrike E E Vollertsen, Ingo H Gorr, Hans Koll, Apollon Papadimitriou
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c60da79177b54a82b4fdb2888fb9f3e0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c60da79177b54a82b4fdb2888fb9f3e0
record_format dspace
spelling oai:doaj.org-article:c60da79177b54a82b4fdb2888fb9f3e02021-11-18T07:13:12ZLow level sequence variant analysis of recombinant proteins: an optimized approach.1932-620310.1371/journal.pone.0040328https://doaj.org/article/c60da79177b54a82b4fdb2888fb9f3e02012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22792284/?tool=EBIhttps://doaj.org/toc/1932-6203Sequence variants in recombinant biopharmaceuticals may have a relevant and unpredictable impact on clinical safety and efficacy. Hence, their sensitive analysis is important throughout bioprocess development. The two stage analytical approach presented here provides a quick multi clone comparison of candidate production cell lines as a first stage, followed by an in-depth analysis including identification and quantitation of aberrant sequence variants of selected clones as a second stage. We show that the differential analysis is a suitable tool for sensitive and fast batch to batch comparison of recombinant proteins. The optimized approach allows for detection of not only single amino acid substitutions in unmodified peptides, but also substitutions in posttranslational modified peptides such as glycopeptides, for detection of truncated or elongated sequence variants as well as double amino acid substitutions or substitution with amino acid structural isomers within one peptide. In two case studies we were able to detect sequence variants of different origin down to a sub percentage level. One of the sequence variants (Thr → Asn) could be correlated to a cytosine to adenine substitution at DNA (desoxyribonucleic acid) level. In the second case we were able to correlate the sub percentage substitution (Phe → Tyr) to amino acid limitation in the chemically defined fermentation medium.Anne ZeckJörg Thomas RegulaVincent LarrailletBjörn MautzOliver PoppUlrich GöpfertFrank WiegeshoffUlrike E E VollertsenIngo H GorrHans KollApollon PapadimitriouPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 7, p e40328 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Anne Zeck
Jörg Thomas Regula
Vincent Larraillet
Björn Mautz
Oliver Popp
Ulrich Göpfert
Frank Wiegeshoff
Ulrike E E Vollertsen
Ingo H Gorr
Hans Koll
Apollon Papadimitriou
Low level sequence variant analysis of recombinant proteins: an optimized approach.
description Sequence variants in recombinant biopharmaceuticals may have a relevant and unpredictable impact on clinical safety and efficacy. Hence, their sensitive analysis is important throughout bioprocess development. The two stage analytical approach presented here provides a quick multi clone comparison of candidate production cell lines as a first stage, followed by an in-depth analysis including identification and quantitation of aberrant sequence variants of selected clones as a second stage. We show that the differential analysis is a suitable tool for sensitive and fast batch to batch comparison of recombinant proteins. The optimized approach allows for detection of not only single amino acid substitutions in unmodified peptides, but also substitutions in posttranslational modified peptides such as glycopeptides, for detection of truncated or elongated sequence variants as well as double amino acid substitutions or substitution with amino acid structural isomers within one peptide. In two case studies we were able to detect sequence variants of different origin down to a sub percentage level. One of the sequence variants (Thr → Asn) could be correlated to a cytosine to adenine substitution at DNA (desoxyribonucleic acid) level. In the second case we were able to correlate the sub percentage substitution (Phe → Tyr) to amino acid limitation in the chemically defined fermentation medium.
format article
author Anne Zeck
Jörg Thomas Regula
Vincent Larraillet
Björn Mautz
Oliver Popp
Ulrich Göpfert
Frank Wiegeshoff
Ulrike E E Vollertsen
Ingo H Gorr
Hans Koll
Apollon Papadimitriou
author_facet Anne Zeck
Jörg Thomas Regula
Vincent Larraillet
Björn Mautz
Oliver Popp
Ulrich Göpfert
Frank Wiegeshoff
Ulrike E E Vollertsen
Ingo H Gorr
Hans Koll
Apollon Papadimitriou
author_sort Anne Zeck
title Low level sequence variant analysis of recombinant proteins: an optimized approach.
title_short Low level sequence variant analysis of recombinant proteins: an optimized approach.
title_full Low level sequence variant analysis of recombinant proteins: an optimized approach.
title_fullStr Low level sequence variant analysis of recombinant proteins: an optimized approach.
title_full_unstemmed Low level sequence variant analysis of recombinant proteins: an optimized approach.
title_sort low level sequence variant analysis of recombinant proteins: an optimized approach.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/c60da79177b54a82b4fdb2888fb9f3e0
work_keys_str_mv AT annezeck lowlevelsequencevariantanalysisofrecombinantproteinsanoptimizedapproach
AT jorgthomasregula lowlevelsequencevariantanalysisofrecombinantproteinsanoptimizedapproach
AT vincentlarraillet lowlevelsequencevariantanalysisofrecombinantproteinsanoptimizedapproach
AT bjornmautz lowlevelsequencevariantanalysisofrecombinantproteinsanoptimizedapproach
AT oliverpopp lowlevelsequencevariantanalysisofrecombinantproteinsanoptimizedapproach
AT ulrichgopfert lowlevelsequencevariantanalysisofrecombinantproteinsanoptimizedapproach
AT frankwiegeshoff lowlevelsequencevariantanalysisofrecombinantproteinsanoptimizedapproach
AT ulrikeeevollertsen lowlevelsequencevariantanalysisofrecombinantproteinsanoptimizedapproach
AT ingohgorr lowlevelsequencevariantanalysisofrecombinantproteinsanoptimizedapproach
AT hanskoll lowlevelsequencevariantanalysisofrecombinantproteinsanoptimizedapproach
AT apollonpapadimitriou lowlevelsequencevariantanalysisofrecombinantproteinsanoptimizedapproach
_version_ 1718423815257587712